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Abstract
A detailed study of the electrochemical oxidative behavior of morphine in aqueous solution is reported. Through the
synthesis of several metabolites and derivatives, pseudomorphine, morphine N-oxide, normorphine, dihydromorphine
and 2-(N,N-dimethylaminomethyl)morphine, and their voltammetric study it was possible to identify the oxidation
peaks for morphine. The anodic waves are related with the oxidation of phenolic and tertiary amine groups. It is also
possible to verify that a poorly defined peak observable during morphine oxidation is not a consequence of further
oxidation of pseudomorphine but due to formation of a dimer during phenolic group oxidation. The results obtained
and especially those regarding the formation of a new polymer based on a CO coupling could be useful for clarifying
the discoloration phenomenon occurring during storage of morphine solutions as well as leading to a better
understanding of its oxidative metabolic pathways.
Keywords: Morphine, Pseudomorphine, Morphine N-oxide, Normorphine, Dihydromorphine, 2-(N,N-
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1. Introduction
The use of medicinals by humans is as old as the human race
itself, since the need to findmeasures to combat sicknesswas
as important as the need for food and shelter. However,
some of these ancient drugs are also among those that pose
serious problems in our contemporary culture through their
extensive use for nonmedical purposes. Since these abused
substances could turn into a substantial risk to the user and
to those with whom he or she may interact, extensive
controls have been placed upon the distribution, possession
and use of these substances. In addition, detailed chemical
and metabolic studies, of a natural or synthetic narcotic,
were found to be crucial for both preventive and repressive
purposes.
A common aspect of drug metabolism is the existence of
one or more oxidative pathways that convert the native
molecular form of the compound into reactive species
capable of chemically modifying vital cellular constituents
[1]. The knowledge of these intermediate metabolites and
the investigation of their reactivity is therefore very
important.
In this context, electrochemical techniques could play a
very important part since besides allowing the detection of
low levels of drugs and metabolites in biological fluids
such as plasma and urine they could also be used for in
vitro studies of the metabolic pathways of these com-
pounds.
Among the commonly encountered types of drugs of
abuse, some of themost important are opium alkaloid drugs
and their derivatives. Commonly used as therapeutic agents,
a number of these compounds are also frequently abused as
illicit drugs. Themost abundant and economically important
opium alkaloid is morphine (Fig. 1). The stability of
morphine in aqueous solution has been extensively inves-
tigated [2]. It is generally accepted that several factors
including oxygen from the air, sunlight and some organic
impurities can catalyze the degradation of morphine. It is
already known that morphine degrades by oxidation and
that the most important products are pseudomorphine and
morphine N-oxide [2].
The oxidative electroactivity of morphine has been
studied by voltammetry using platinum, graphite and glassy
carbon electrodes [3 ± 5]. It has been determined that the
phenolic group present is responsible for its electroactivity.
The existence of some gaps in knowledge regarding the
oxidative behavior of morphine prompted the detailed
study described in this paper. In order to identify the
oxidation processes and the products formed, several
morphine derivatives were synthesized and their electro-
chemical behavior studied, pseudomorphine, morphine N-
oxide, normorphine and 2-(N,N-dimethylaminomethyl)-
morphine (Fig. 1).
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2. Experimental
2.1. Apparatus
Voltammetric measurements were performed using an
Autolab PGSTAT 10 potentiostat/galvanostat (EcoChimie,
Netherlands) and a one-compartment glass 663 VA Met-
rohm cell with a three-electrode configuration (Metrohm).
The electrodes used were a glassy carbon working electrode
with a diameter of 2 mm (Metrohm), a glassy carbon rod
counter electrode (Metrohm) and an Ag/AgCl (3 M KCl)
reference electrode (Metrohm). The working electrode was
polished with alumina (BDH) on a microcloth pad and
rinsed with water before use.
A Metrohm E-520 pH-meter and a Metrohm glass
electrode were used for pH measurements. Melting points
were measured using a Kˆfler microscope (Reichert Ther-
movar). Infrared spectra were recorded on an ATIMattson
Genesis Series FTIR spectrophotometer using potassium
bromide disks (Uvasol, Merck). 1H and 13C NMR (1H
decoupled) data were acquired, at room temperature, on a
Br¸ker AMX 300 spectrometer operating at 300.13 and
75.47 MHz, respectively. Electron impact mass spectra (EI-
MS) were obtained on a VG AutoSpec instrument.
2.2. Other Conditions
Thin-layer chromatography (TLC) was performed on pre-
coated silica gel 60 F254 and cellulose plates (E. Merck).
The layer thickness was 0.2 and 0.1 mm, respectively. The
following chromatographic systems were used: n-butanol/
water/acetic acid (4 :1 : 1), water/methanol/acetic acid
(8 :2 : 0.1), acetone/water/ammonia (8 :1.5 : 0.5), chloroform/
methanol/diethylamine (8 :1.5 :0.5), carbon tetrachloride/
butanol/methanol/ammonia (4 :3 :3 : 0.3), chloroform/meth-
anol (9 :1), dichloromethane/diethylamine (9 :1). The spots
were visualized under UV detection (254 and 366 nm) and
iodine vapor. Purification of the compounds was performed
by column chromatography using Merck silica gel 60 (0.2 ±
0.5 and 0.040 ± 0.063 mm, E. Merck) or aluminium oxide,
activated basic, Brockmann I (ca. 150 mesh, 58 ä, Aldrich).
Solvents were evaporated in a B¸chi Rotavapor.
2.3. Reagents and Solutions
Morphine hydrochloride was obtained from Uquipa (Lis-
bon, Portugal) and was used without further purification.
Dihydromorphine hydrochloride was kindly donated by the
United Nations Drug Control Program (Vienna, Austria).
Reagents used in the synthetic procedures were obtained
from Sigma-Aldrich Quimica (Sintra, Portugal). All other
reagents and solventswerepro analysis grade andpurchased
from Merck (Lisbon, Portugal). m-Chloroperbenzoic acid
(free of m-chlorobenzoic acid) was purified according the
procedure of Bortolini et al. [6]. Deionized water with
conductivity less than 0.1 S cm1 was used throughout.
Buffer solutions employed were 0.2 M in the pH range 1.2 ±
12.2 [7].
2.3.1. Synthesis of Pseudomorphine (2,2-Bimorphine;
Oxydimorphine)
The synthetic procedure was adapted from the literature
[8 ± 10].
Morphine hydrochloride (1.0 g) was dissolved, with heat-
ing, in 200 mL of 20% potassium hydroxide. After cooling,
40 mL of a 3% potassium ferricyanide solution was slowly
added dropwise. The reactionwas stirred during 30 min. and
refrigerated overnight. The solid obtained was filtered and
washed with warm methanol. In TLC analysis pseudomor-
phine appears as a fluorescent spot [11 ± 14].
Due to the low solubility of the compound in water, the
sulfate salt was prepared by dissolving the free base in warm
glacial acetic acid and adding sulfuric acid until the
formation of a precipitate. The product was filtered and
recrystallized from water. The compound was filtered,
thoroughly washed with water, then with ethyl ether and
dried under vacuum.
The analytical data obtained for pseudomorphine was
similar to that found in the literature [10, 11, 13, 15].
Fig. 1. Structural formulae of a) morphine, b) pseudomorphine,
c) morphine N-oxide, d) normorphine, e) dihydromorphine and f)
2-(N,N-dimethylaminomethyl)morphine.
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2.3.2. Synthesis of Morphine N-oxide (Morphine Oxide)
Morphine free base was first prepared in order to be used in
the subsequent preparationofmorphineN-oxide.Morphine
hydrochloride (1.0 g) was dissolved in 25 mL of water
containing a trace of sodium metabisulfite at 10 C. One
equivalent of concentrated aqueous ammonia was added
dropwise, with stirring. The cooling was continued for an
additional 15 min. and during this time a white solid
appeared in the solution. The crystals were filtered and
washed with ice-cold water.
The synthesis of morphine N-oxide was then carried out
using two different procedures adapted from the literature:
1) Morphine base (0.6 g) was added to 1.5 mL of an ice-
cooled 30%hydrogen peroxide solution. The slurry was
stirred during 15 min. and then was slowly heated in a
water bath till complete dissolution.Acetonewas added
to cause precipitation. The solid obtained was filtered,
washed with acetone and dried in an oven [16, 17].
2) Alternatively morphine N-oxide was synthesized using
m-chloroperbenzoic acid as oxidant as proposed by
Craig and Purushothaman [18]. A solution of m-
chloroperbenzoic acid (0.25 g) in 5 mL of chloroform
was gradually added, at 0 ± 5 C, to an ice-cooled stirred
solution of morphine (0.2 g) in 5 mL of chloroform/
methanol (1 : 1). Stirring was continued for 6 hours,
during which time the mixture was allowed to warm till
room temperature. The solvent was evaporated and the
residue obtained was purified by column chromatog-
raphy (alkaline alumina; chloroform chloroform/
methanol 7 :3).
TLC analysis of the product obtained by both methods
revealed the presence of two morphine N-oxide isomers in
different proportions. Before purification, the compounds
were converted into the sulfate salt form. After preparative
TLC the major isomer was isolated (silica gel; chloroform/
methanol/diethylamine (8 :1.5 : 0.5)). The analytical data of
the compound were similar to those found in the literature
[16, 17, 19, 20].
2.3.3. Synthesis of Normorphine (Desmethylmorphine)
Normorphine was synthesized following a previously de-
scribed procedure [21]. To a suspension of morphine (0.5 g)
and sodium bicarbonate (2.38 g) in 50 mL of chloroform,
phenylchloroformate (2.16 g) was added. The mixture was
refluxed for 60 hours. The solvent was partially evaporated
and 30 mL of water was added. After acidification with
concentrated hydrochloric acid, the mixture was extracted
with chloroform (3 50 mL). The organic extracts were
combined, washedwithwater, dried over anhydrous sodium
sulfate and concentrated. A volume of 20 mL of 95%
hydrazine was added to the crude product and the solution
was refluxed under nitrogen for 60 hours. After cooling,
20 mL of water was added and washed with ethyl acetate
(2 50 mL). The aqueous phase was acidified till pH 2 with
concentrated hydrochloric acid. The product was filtered
and redissolved in water. After alkalinization with concen-
trated aqueous ammonia a precipitate was formed, filtered
and washed with water. The compound has the same
chromatographic behavior as normorphine standard.
2.3.4. Synthesis of 2-(N,N-Dimethylaminomethyl)mor-
phine (2-(N,N-dimethylaminomethyl)-4,5--epoxy-
17-metyl-morphin-7-en-3,6--di ol)
This synthesis was adapted from a reported procedure with
slightmodifications [22].Morphine (0.58 g) was dissolved in
30 mL of anhydrous acetonitrile and N,N-dimethylmethy-
leneiminium chloride (0.4 g) was added to the solution. The
mixture was refluxed for 12 hours. After evaporation of the
solvent, the remaining residue was purified by flash
chromatography (alkaline alumina; dichloromethane/dieth-
ylamine 9 :1).
The analytical data were similar to those referred in the
literature [22].
3. Results and Discussion
The degradation of morphine in aqueous solution was
extensively studied since discoloration occurs during stor-
age of morphine solutions. It is already known that the
degradation process is mainly dependent on the pH of the
solution and on the presence of atmospheric oxygen [2].
Although some of the morphine degradation products are
already known, involving oxidation to pseudomorphine and
morphine N-oxide, the yellowish to brown discoloration of
morphine solutions occurring during storage remains un-
explained.
With the aim of clarifying and proving the oxidative
mechanism of morphine, several specific congeners were
synthesized: pseudomorphine, morphine N-oxide, normor-
phine and 2-(N,N-dimethylaminomethyl)morphine, as de-
scribed in the experimental section. The selected com-
pounds possess important functionalities that could help in
understanding the oxidative profile of morphine.
3.1. Electrochemical Oxidation
In order to clarify the oxidative pathways of morphine, its
electrochemical behavior was studied over a wide pH range
(between 1.2 and 12.2) at a glassy carbon working electrode
(GCE) using differential pulse voltammetry (Figs. 2a and
2b). Excluding the broad peak observed at 0.3 V from
pH 1 to 3, that is related with the GCE background current,
two well-defined anodic peaks can be observed. The first
peak starting at pH 1,Ep0.7 V, is due to the oxidation of
the phenolic group. The second wave starting at pH 4, Ep
1.1 V, corresponds to the oxidation of the tertiary amine
group. It was found that the values of Ep for both peaks
shifted to more negative potentials with increasing pH,
(Fig. 2b), corresponding to amechanism involving the same
number of electrons and protons [23]. These results are in
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agreement with the data found in the literature [5].
However, a less obvious peak is also referred to between
the first and the second peak; it was suggested to be due to
further oxidation of pseudomorphine, the product resulting
from oxidation of the phenolic group [5]. At first sight, from
the results obtained in this work, it was not possible to
observe the presence of this peak. However, expanding the
current scale of the voltammograms obtained between pH 5
to 7 a small shoulder, indicated by the arrow, at approx-
imately 0.8 V is observable (Fig. 3).
To clarify the occurrence of this peak, to prove that the
groups involved in the oxidation are the phenolic and
tertiary amine and in order to establish the oxidative
pathways of morphine a comprehensive electrochemical
study of severalmetabolites and derivatives was carried out.
The electrochemical behavior of pseudomorphine, mor-
phineN-oxide, normorphine, dihydromorphine and 2-(N,N-
dimethylaminomethyl) morphine, was studied at a glassy
carbon working electrode using differential pulse voltam-
metry over the pH range 1.2 to 12.2 (Fig. 4).
Considering the voltammetric behavior and molecular
structure of normorphine and particularly of morphine N-
oxide (Figs. 1, 4c and 4d) it can be readily concluded that the
second anodic wave that starts atEp1.1 V for morphine
must correspond to the oxidation of the tertiary amine
group, i.e., the non-existence of this wave for these
compounds is related with the absence of a tertiary amine
group in their structure. Since the oxidation of a tertiary
amine gives rise to a secondary amine and an aldehyde [24] it
can be deduced that one of the main oxidative products of
morphine is normorphine (Scheme 1). Particular attention
should be given to the second peak observed for normor-
phine (Fig. 4d). The appearance of this wave is related with
the oxidation of the secondary amine group present in the
molecular structure. Although this oxidative pattern is
already referred to in the literature for secondary amines
[25, 26], further evidence was obtained by studying a closely
structurally related compound, norheroin (data not shown).
The results obtained clearly demonstrate that the second
peak observed for normorphine is indeed connected with
the oxidation of the secondary amine group.
The assignment of the first peak for morphine at pH 1,
Ep0.7 V, to the oxidation of the phenolic group could be
easily proved. The oxidation of codeine or ethylmorphine
which have methoxy and ethoxy groups, respectively,
instead of a phenolic group in the 3-position, was studied
and the first peak was obtained only at potentials higher
than1.0 V (data not shown). Theoxidationof the phenolic
group leads to the formation of pseudomorphine as themain
product, as already suggested [3, 5] (Scheme 1). This
product, obtained from oxidation of the phenolic group, is,
according to the literature [5], responsible for the poorly
defined peak occurring at 0.8 V for morphine, since the
structure of pseudomorphine (Fig. 1b) possesses two phe-
nolic groups that could be susceptible to further oxidation.
To verify this assumption the oxidative behavior of
pseudomorphine was analyzed. As seen in Fig. 4b there
are two well-defined peaks occurring at the same potential
as for morphine (Fig. 4a). Moreover, at some pHs, it is also
possible to observe a third poorly-defined peak at Ep
0.8 V. From these results it can be concluded that the
Fig. 2. a) 3D plot and b) plots of Ep (filled symbols) and Ip (open
symbol) vs. pH from differential pulse voltammograms of 100 M
morphine in different buffer electrolytes as function of pH. Scan
rate 5 mV s1.
Fig. 3. Differential pulse voltammogram of a 100 M solutions
of morphine in pH 7 phosphate buffer. Scan rate 5 mV s1.
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presence of two phenolic groups in the pseudomorphine
molecule makes possible its further oxidation but, as seen,
the oxidation occurs at the same potential as morphine.
Another important deduction is that the peak current for
pseudomorphine for all pHs studied is approximately
double that obtained for morphine (Fig. 5). This is expected
given the presence of two symmetric phenolic groups in the
pseudomorphinemolecule. Thus, if the product of oxidation
of the phenolic group present in morphine, was pseudomor-
phine, which then underwent further oxidation the peak
obtained would not appear at the cited potential 0.8 V.
This occurrence of the peak at 0.8 V assumes more
importance considering that it appears very well-defined at
several pHs in the voltammograms of morphine N-oxide
and normorphine (Figs. 4c, 4d and 6). The oxidation of
aliphatic alcohols usually occurs at high potentials. How-
ever, the presence of a double bond in morphine in the
neighborhood of the hydroxy group at the 6-position, that
also appears in morphine N-oxide and normorphine
(Fig. 1a, 1c and 1d), will influence the mechanism. The fact
that it is stated in the literature that a metabolite resulting
from the oxidation of this group (morphinone) occurs in
vivo [27], led us to study the electrochemical behavior of
dihydromorphine (Fig. 1e). As seen in Figure 4e, this
compound has an identical oxidation profile to that of
morphine and so it is unlikely that the hydroxy group in the
6-position is responsible for the unidentified peak.
In order to verify if the formation of a dimer, different
from pseudomorphine, could be responsible for the appear-
ance of this peak, a derivative of morphine blocked at the 2-
Fig. 4. Plots of Ep vs. pH from differential pulse voltammograms of 100 M solutions of a) morphine, b) pseudomorphine, c) morphine
N-oxide, d) normorphine, e) dihydromorphine and f) 2-(N,N-dimethylaminomethyl)morphine in different buffer electrolytes. Scan rate
5 mV s1. (–) Slope 59.2 mV/pH unit.
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position, 2-(N,N-dimethylaminomethyl)morphine (Fig. 1f),
was synthesized and studied voltammetrically (Fig. 4f).
Figure 6 shows the behavior of morphine N-oxide and 2-
(N,N-dimethylaminomethyl) morphine at pH 5, the pH at
which the peak at 0.8 V was best defined for morphine.
The results obtained show that this peak is absent in 2-(N,N-
dimethylaminomethyl) morphine at all pHs and therefore,
an unrestrained 2-position is necessary for appearance of
this peak.
Thus, considering the results discussed previously, the
peak at 0.8 V should result from further oxidation of a
dimer (Scheme 2), other thanpseudomorphine, arising from
the oxidation of the phenolic group present in morphine.
The formation of a second, different dimer, other than
pseudomorphine, by partial oxidation of morphine has
already been reported in the literature [28].
The occurrence of another dimeric form is also proposed
during the degradation of morphine and consequent pro-
duction of pseudomorphine by direct analogy to what is
found for the oxidation of p-cresol [2]. Considering the
oxidation mechanism for phenol the occurrence of this
second dimer can be explained. It is well-known that the
oxidation of a phenolic group gives rise to a semiquinone
that exists in equilibrium with the corresponding quinone
(Scheme 2). According to the literature, it is this quinone
that undergoes coupling with protonated or free base
morphine resulting in the formation of the dimer pseudo-
morphine [2]. Nevertheless, the existence of the semi-
quinone in the equilibrium cannot be neglected leading to
the formation of dimeric forms such as an ether (Scheme 2).
In this way, it is reasonable to suppose that the unidenti-
fied peak, at0.8 V, obtained for the oxidation ofmorphine
is a consequence of further oxidation of this dimer formed
jointly with pseudomorphine by oxidation of the phenolic
group. A similar dimer was recently prepared by oxidation
of 2-hydroxymethylmorphine making this hypothesis even
Fig. 5. Differential pulse voltammograms in pH 7 phosphate
buffer of 100 M solutions: (–) morphine and (±) pseudomor-
phine. Scan rate 5 mV s1.
Fig. 6. Differential pulse voltammograms in pH 5 acetate buffer
of 100 M solutions: (±) morphine N-oxide and ( ¥¥¥ ¥ ¥ ) 2-(N,N-
dimethylaminomethyl) morphine. Scan rate 5 mV s1.
Scheme 1.
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more likely [29]. This dimer and the possibility of further
oxidation leading to polymers could also be an explanation
for the yellowish to brown discoloration observed in
morphine solutions during storage.
Apomorphine has been proposed as a degradation
product of morphine [30] and since this constitutes a subject
of some controversy [31] some studiesweredonewith a view
to contributing to clarify this matter. Nevertheless, the
formation of apomorphine from morphine appears to
require heating up to 60 ± 65 C in concentrated HCl for
2 ± 3 h [31, 32]. The voltammetric results obtained in pH 3
acetate buffer for morphine and pseudomorphine (Fig. 7)
suggests that apomorphine can also be a minor product
formed as a result of the occurrence of a side reaction. In
fact, comparing the peak appearing at this pH, for both
compounds, at approximatelyEp0.3 V with the voltam-
metric behavior of apomorphine at the same pH some
similarities are encountered (Fig. 7). Considering that the
acidic rearrangement of morphine to apomorphine is al-
ready well described [32] and in order to verify if the
amplitude of this peak is time-dependent a studywas carried
out in pH 3 acetate buffer for morphine. The results
obtained are not conclusive since an increase in peak
current occurred during the first 5 h but there was a sudden
decrease after 24 hours. This behavior could in part be
justified by the oxidative profile of apomorphine since in
aqueous solutions degradation easily occurs [33]. An
attempt to prove apomorphine formation by cyclic voltam-
metry was also unsuccessful since this technique does not
have sufficient sensitivity and it was not possible to detect
the occurrence of this peak formorphine.More studies need
to be carried out in order to clarify and justify the results
obtained.
4. Conclusions
The electrochemical oxidative behavior of morphine in
aqueous solution was studied and was found to be complex
and pH-dependent. To elucidate and clarify the voltam-
metric waves obtained several metabolites and derivatives,
pseudomorphine, morphine N-oxide, normorphine, dihy-
dromorphine and 2-(N,N-dimethylaminomethyl)morphine,
were synthesized and studied.
Two well-defined anodic peaks were found for morphine
oxidation that were related, to the oxidation of phenol and
tertiary amine groups, after a detailed study and comparison
with the oxidative profile of several congener compounds.
Moreover, the poorly defined peak seen for morphine
oxidation is clearly visible for normorphine and morphine
N-oxide suggesting that it is relatedwith further oxidation of
a dimer different from pseudomorphine. This conclusion
Scheme 2.
Fig. 7. Differential pulse voltammograms in pH 3 acetate buffer
of 100 M solutions: (–) morphine, ( ¥¥ ¥ ¥ ) apomorphine and
(- - - -) pseudomorphine. Scan rate 5 mV s1.
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could be very important for interpreting discoloration
phenomena of morphine solutions besides contributing to
understand oxidative metabolic pathways and biological
interactions of morphine.
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